Pages that link to "Q34681455"
Jump to navigation
Jump to search
The following pages link to MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1. (Q34681455):
Displaying 50 items.
- Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10 (Q21089590) (← links)
- Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa (Q27322437) (← links)
- Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity (Q27654848) (← links)
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield (Q27675032) (← links)
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody (Q27675131) (← links)
- A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition (Q27676864) (← links)
- Structural Basis for Broad Detection of Genogroup II Noroviruses by a Monoclonal Antibody That Binds to a Site Occluded in the Viral Particle (Q27676892) (← links)
- Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1 (Q28250040) (← links)
- Virus neutralisation: new insights from kinetic neutralisation curves (Q28487427) (← links)
- Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes (Q28539672) (← links)
- Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1) (Q28743199) (← links)
- Gene Mining for Proline Based Signaling Proteins in Cell Wall of Arabidopsis thaliana (Q30178311) (← links)
- Stabilized HIV-1 envelope glycoprotein trimers for vaccine use. (Q30490942) (← links)
- A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1. (Q31132248) (← links)
- Estimating the probability of polyreactive antibodies 4E10 and 2F5 disabling a gp41 trimer after T cell-HIV adhesion (Q31151010) (← links)
- Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions (Q33680883) (← links)
- HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies (Q33753573) (← links)
- Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization (Q33946158) (← links)
- A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus (Q33954392) (← links)
- Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. (Q34109778) (← links)
- Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies (Q34229664) (← links)
- Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function (Q34350894) (← links)
- Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization (Q34441935) (← links)
- Designer antigens for elicitation of broadly neutralizing antibodies against HIV. (Q34511575) (← links)
- Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. (Q34544718) (← links)
- Increased functional stability and homogeneity of viral envelope spikes through directed evolution (Q34611144) (← links)
- MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide (Q34784621) (← links)
- Receptor binding domain based HIV vaccines. (Q35033862) (← links)
- Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies (Q35102328) (← links)
- Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies (Q35110992) (← links)
- Structure and immune recognition of trimeric pre-fusion HIV-1 Env. (Q35142291) (← links)
- Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1). (Q35154031) (← links)
- Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent (Q35686912) (← links)
- Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions (Q35689608) (← links)
- Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes (Q35745442) (← links)
- Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion (Q35842116) (← links)
- Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection (Q35842299) (← links)
- Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry (Q35974165) (← links)
- Discrete partitioning of HIV-1 Env forms revealed by viral capture. (Q36088254) (← links)
- Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike (Q36100426) (← links)
- Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2. (Q36123526) (← links)
- Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer. (Q36228646) (← links)
- Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. (Q36298503) (← links)
- M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding (Q36608485) (← links)
- Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein (Q37123584) (← links)
- Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors (Q37286064) (← links)
- HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study (Q37484124) (← links)
- Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. (Q37547462) (← links)
- Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins (Q37593177) (← links)
- Fate of microglia during HIV-1 infection: From activation to senescence? (Q38790617) (← links)